Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis
Nicholas J. Vogelzang
Sumanta K. Pal
Sameer R. Ghate
Elyse Swallow
Miranda Peeples
Miriam L. Zichlin
Mark K. Meiselbach
Jose Ricardo Perez
Neeraj Agarwal
10.6084/m9.figshare.6200879.v1
https://adisjournals.figshare.com/articles/figure/Clinical_and_Economic_Outcomes_in_Elderly_Advanced_Renal_Cell_Carcinoma_Patients_Starting_Pazopanib_or_Sunitinib_Treatment_A_Retrospective_Medicare_Claims_Analysis/6200879
<p><strong>Article full
text</strong></p>
<p><br>
The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s12325-017-0628-2"><b>here</b>.</a><br>
<br>
<strong>Provide enhanced digital features for this article</strong><br>
If you are an author of this publication and would like to provide additional
enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are
not limited to:<br>
• Slide decks<br>
• Videos and animations<br>
• Audio abstracts<br>
• Audio slides<u></u></p><br>
2018-04-30 15:28:55
Advanced renal cell carcinoma
Claims analysis
Elderly
Healthcare costs
Healthcare resource utilization
Medicare
Overall survival
Pazopanib
Sunitinib